ID16856A - Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan - Google Patents

Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan

Info

Publication number
ID16856A
ID16856A IDP971466A ID971466A ID16856A ID 16856 A ID16856 A ID 16856A ID P971466 A IDP971466 A ID P971466A ID 971466 A ID971466 A ID 971466A ID 16856 A ID16856 A ID 16856A
Authority
ID
Indonesia
Prior art keywords
subazed
subditions
connected compounds
compounds
subazed subditions
Prior art date
Application number
IDP971466A
Other languages
English (en)
Indonesian (id)
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ID16856A publication Critical patent/ID16856A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDP971466A 1996-05-03 1997-05-02 Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan ID16856A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1686196P 1996-05-03 1996-05-03

Publications (1)

Publication Number Publication Date
ID16856A true ID16856A (id) 1997-11-13

Family

ID=21779401

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971466A ID16856A (id) 1996-05-03 1997-05-02 Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan

Country Status (41)

Country Link
US (2) US6211222B1 (de)
EP (1) EP0912521B1 (de)
JP (1) JP3148254B2 (de)
KR (1) KR100339935B1 (de)
CN (2) CN1112359C (de)
AP (4) AP1147A (de)
AR (1) AR006906A1 (de)
AT (1) ATE292626T1 (de)
AU (1) AU725576B2 (de)
BG (1) BG64211B1 (de)
BR (1) BR9709051A (de)
CA (2) CA2389918A1 (de)
CO (1) CO4650038A1 (de)
CZ (1) CZ292825B6 (de)
DE (1) DE69732966T2 (de)
DZ (1) DZ2217A1 (de)
EA (1) EA002272B1 (de)
ES (1) ES2238079T3 (de)
GT (1) GT199700043A (de)
HN (1) HN1997000046A (de)
HR (1) HRP970227B1 (de)
HU (1) HUP9902459A3 (de)
ID (1) ID16856A (de)
IL (2) IL126547A (de)
IS (1) IS4871A (de)
MA (1) MA24158A1 (de)
MY (1) MY132499A (de)
NO (1) NO312959B1 (de)
NZ (1) NZ332240A (de)
OA (1) OA10904A (de)
PE (1) PE64598A1 (de)
PL (1) PL329836A1 (de)
SK (1) SK148298A3 (de)
TN (1) TNSN97070A1 (de)
TR (1) TR199802202T2 (de)
TW (1) TW449585B (de)
UA (1) UA65536C2 (de)
UY (1) UY24532A1 (de)
WO (1) WO1997042174A1 (de)
YU (1) YU16397A (de)
ZA (1) ZA973804B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005118A (en) * 1996-05-03 1999-12-21 Caron; Stephane Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
AP1147A (en) * 1996-05-03 2003-02-25 Pfizer Substituted indazole derivatives and related compounds.
JP4373497B2 (ja) 1996-06-19 2009-11-25 ローン−プーラン・ロレ・リミテツド 置換されたアザビシクロ化合物、ならびにtnfおよびサイクリックampホスホジエステラーゼ産生の阻害剤としてのそれらの使用
US6011159A (en) 1997-05-08 2000-01-04 Pfizer Inc Processes and intermediates for preparing substituted indazole derivatives
IL126745A (en) * 1997-11-04 2003-09-17 Pfizer Prod Inc Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors
IL135714A0 (en) * 1997-11-04 2001-05-20 Pfizer Prod Inc Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
IL135900A0 (en) * 1997-11-04 2001-05-20 Pfizer Prod Inc Indazole bioisostere replacement of catechol in therapeuticaly active compounds
IL132407A0 (en) * 1998-10-21 2001-03-19 Pfizer Prod Inc Method for treating congestive heart failure
JP2000198734A (ja) * 1998-12-30 2000-07-18 Pfizer Inc 胃運動性減弱および関連疾患の治療のための運動性増強薬
US6303782B1 (en) * 1999-04-20 2001-10-16 Pfizer Inc Process for preparing benzylnitriles
US6362213B1 (en) 1999-12-23 2002-03-26 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
PT1244649E (pt) * 1999-12-23 2005-06-30 Icos Corp Inibidores de fosfodiesterase especificos de mfa ciclica
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
US7211594B2 (en) * 2000-07-31 2007-05-01 Signal Pharmaceuticals, Llc Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
US6953774B2 (en) 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation
US7507707B2 (en) 2001-12-14 2009-03-24 Laboratoires Serono Sa Methods of inducing ovulation using a non-polypeptide camp level modulator
US20040034084A1 (en) * 2002-05-24 2004-02-19 Celgene Corporation Methods for using JNK inhibitors for treating or preventing disease-related wasting
US7196082B2 (en) * 2002-11-08 2007-03-27 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
US20050019366A1 (en) * 2002-12-31 2005-01-27 Zeldis Jerome B. Drug-coated stents and methods of use therefor
DE10318610A1 (de) 2003-04-24 2004-11-11 Elbion Ag 7-Azaindole und deren Verwendung als Therapeutika
US7601847B2 (en) 2004-10-26 2009-10-13 Wyeth Preparation and purification of 4-(indazol-3-yl)phenols
US20070004777A1 (en) * 2005-03-23 2007-01-04 Bhagwat Shripad S Methods for treating or preventing acute myelogenous leukemia
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
EP2275095A3 (de) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007124414A2 (en) * 2006-04-21 2007-11-01 Centocor, Inc. Cxcl13 antagonists and their use for the treatment of inflammatory diseases
EP2382975A3 (de) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
EP3706750A1 (de) 2017-11-06 2020-09-16 RAPT Therapeutics, Inc. Chemokinrezeptor-modulatoren zur behandlung von epstein-barr-virus-positivem krebs

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994890A (en) * 1974-01-31 1976-11-30 Chugai Seiyaku Kabushiki Kaisha 1-Aminoalkyl, 3-phenyl indazoles
JPS5654437A (en) * 1979-10-09 1981-05-14 Konishiroku Photo Ind Co Ltd Direct positive image forming method
GB8707051D0 (en) * 1986-04-15 1987-04-29 Ici America Inc Heterocyclic carboxamides
JP2525286B2 (ja) * 1990-11-26 1996-08-14 日本原子力研究所 超耐熱性炭化ケイ素繊維の製造方法
TW223004B (de) * 1991-11-25 1994-05-01 Sumitomo Chemical Co
PT630367E (pt) * 1992-03-09 2000-10-31 Zeneca Ltd Novos arilindazoles e sua utilizacao como herbicidas
US5444038A (en) * 1992-03-09 1995-08-22 Zeneca Limited Arylindazoles and their use as herbicides
US5552438A (en) * 1992-04-02 1996-09-03 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
US5554620A (en) * 1993-09-14 1996-09-10 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof
US5440038A (en) * 1993-12-07 1995-08-08 Miles Inc. Process for the purification of substituted 4-amino-1,2,4-triazine-5-ones
KR970707124A (ko) * 1994-10-20 1997-12-01 스피겔 알렌 제이 비사이클릭 테트라하이드로 피라졸로피리딘 및 약제로서 이의 용도(bicyclic tetrahydro pyrazolopyridines and their use as medicaments)
CA2203181C (en) * 1994-10-21 2001-08-07 Robert L. Heimann Corrosion preventing buffer system for metal products
AP1147A (en) * 1996-05-03 2003-02-25 Pfizer Substituted indazole derivatives and related compounds.
US6011159A (en) * 1997-05-08 2000-01-04 Pfizer Inc Processes and intermediates for preparing substituted indazole derivatives

Also Published As

Publication number Publication date
HUP9902459A3 (en) 2001-10-29
ATE292626T1 (de) 2005-04-15
OA10904A (en) 2001-10-11
CN1422849A (zh) 2003-06-11
WO1997042174A1 (en) 1997-11-13
SK148298A3 (en) 2000-02-14
HUP9902459A2 (hu) 1999-11-29
HRP970227A2 (en) 2000-12-31
AP1147A (en) 2003-02-25
PL329836A1 (en) 1999-04-12
ZA973804B (en) 1998-11-02
UA65536C2 (en) 2004-04-15
TW449585B (en) 2001-08-11
AU725576B2 (en) 2000-10-12
MY132499A (en) 2007-10-31
CO4650038A1 (es) 1998-09-03
EP0912521A1 (de) 1999-05-06
BR9709051A (pt) 1999-08-03
AU1937397A (en) 1997-11-26
HK1019443A1 (en) 2000-02-11
KR20000010751A (ko) 2000-02-25
EP0912521B1 (de) 2005-04-06
AR006906A1 (es) 1999-09-29
IL126547A0 (en) 1999-08-17
DE69732966T2 (de) 2005-09-08
IS4871A (is) 1998-10-16
US6127398A (en) 2000-10-03
BG64211B1 (bg) 2004-05-31
CA2252982A1 (en) 1997-11-13
EA199800882A1 (ru) 1999-06-24
NO985095D0 (no) 1998-11-02
CN1112359C (zh) 2003-06-25
KR100339935B1 (ko) 2002-07-18
AP2001002294A0 (en) 2001-12-31
CA2389918A1 (en) 1997-11-13
AP9700975A0 (en) 1997-07-31
DZ2217A1 (fr) 2002-12-03
CZ349298A3 (cs) 1999-09-15
AP0102304A0 (en) 1997-11-03
TNSN97070A1 (fr) 2005-03-15
TR199802202T2 (xx) 1999-02-22
DE69732966D1 (de) 2005-05-12
HRP970227B1 (en) 2002-06-30
IL126547A (en) 2003-03-12
HN1997000046A (es) 1997-06-26
AP2001002304A0 (en) 2001-12-31
IL152083A0 (en) 2003-05-29
NO312959B1 (no) 2002-07-22
GT199700043A (es) 1998-10-02
BG102946A (en) 1999-11-30
UY24532A1 (es) 2000-09-29
US6211222B1 (en) 2001-04-03
AP1146A (en) 2003-02-25
NO985095L (no) 1998-12-29
JPH11508284A (ja) 1999-07-21
PE64598A1 (es) 1998-10-26
NZ332240A (en) 2000-07-28
JP3148254B2 (ja) 2001-03-19
CA2252982C (en) 2002-10-08
EA002272B1 (ru) 2002-02-28
CZ292825B6 (cs) 2003-12-17
MA24158A1 (fr) 1997-12-31
ES2238079T3 (es) 2005-08-16
YU16397A (sh) 1999-12-27
CN1217714A (zh) 1999-05-26

Similar Documents

Publication Publication Date Title
ID16856A (id) Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan
ID22426A (id) Ketobenzamida yang baru dan penggunaannya
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID19422A (id) Piridina dan bifenil tersubstitusi
NO993068D0 (no) Ny forbindelsesform
ID19833A (id) Aralkil dan aralkilidena heterosiklik laktam dan imida
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
ID23684A (id) Komposisi-polimer-organoclay dan pembuatannya
ID25651A (id) Senyawa-senyawa bisiklo [2.2.1] heptana dan senyawa-senyawa yang terkait
EG21153A (en) Use of oil and gasfield chemicals
IS5419A (is) Vatnshreinsunar- og vatnsmiðlunartæki
ID18682A (id) Asiltransferase dan plasma yang mengkodekan asiltransferase
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
DE69617446D1 (de) Verriegelungseinheit
DE59709250D1 (de) Konvertergehäuse
ID21770A (id) Plester yang mengandung felbinak
ID18459A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID19147A (id) Ksilanase dan pemakaiannya
ID16587A (id) Koproduksi 6-aminokapronitril dan heksametilendiamin
EP0964691A4 (de) Verwendung von conantokine
ID18913A (id) Turunan turunan tienopiridin dan penggunaannya
ID21419A (id) Saklar dan peralatan saklar yang menggunakan saklar
FI964026L (fi) Hierontalaite
ID17395A (id) Aluminosilikat berbentuk beraturan dan penggunaannya